NASDAQ:FTRE Fortrea (FTRE) Stock Price, News & Analysis → Crypto Millionaire Says: “Buy This $11 AI Coin.” (From InvestorPlace) (Ad) Free FTRE Stock Alerts $28.11 -4.92 (-14.90%) (As of 05/13/2024 ET) Add Compare Share Share Today's Range$26.63▼$29.2750-Day Range$28.11▼$40.2852-Week Range$24.92▼$41.02Volume7.63 million shsAverage Volume974,470 shsMarket Capitalization$2.51 billionP/E RatioN/ADividend YieldN/APrice Target$37.29 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Fortrea alerts: Email Address Fortrea MarketRank™ Stock AnalysisAnalyst RatingHold2.38 Rating ScoreUpside/Downside32.6% Upside$37.29 Price TargetShort InterestBearish7.41% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.70Based on 16 Articles This WeekInsider TradingN/AProj. Earnings Growth91.51%From $1.06 to $2.03 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.10 out of 5 starsMedical Sector1854th out of 2,771 stocksMedical Laboratories Industry37th out of 57 stocks 3.2 Analyst's Opinion Consensus RatingFortrea has received a consensus rating of Hold. The company's average rating score is 2.38, and is based on 4 buy ratings, 3 hold ratings, and 1 sell rating.Amount of Analyst CoverageFortrea has only been the subject of 2 research reports in the past 90 days.Read more about Fortrea's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted7.41% of the float of Fortrea has been sold short.Short Interest Ratio / Days to CoverFortrea has a short interest ratio ("days to cover") of 7.8.Change versus previous monthShort interest in Fortrea has recently increased by 41.85%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldFortrea does not currently pay a dividend.Dividend GrowthFortrea does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for FTRE. Previous Next 3.7 News and Social Media Coverage News SentimentFortrea has a news sentiment score of 0.70. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 16 news articles for Fortrea this week, compared to 3 articles on an average week.Search Interest2 people have searched for FTRE on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows1 people have added Fortrea to their MarketBeat watchlist in the last 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Fortrea insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.12% of the stock of Fortrea is held by insiders.Read more about Fortrea's insider trading history. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Fortrea are expected to grow by 91.51% in the coming year, from $1.06 to $2.03 per share.Price to Earnings Growth RatioFortrea has a PEG Ratio of 1.65. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioFortrea has a P/B Ratio of 1.44. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad InvestorPlaceElon Musk’s Next Move Will Disrupt AI ForeverA revolutionary venture that is set to get rolled out by May 16. One well-connected Silicon Valley VC has uncovered a way for anybody to claim a stake in "Elon Musk's AI 2.0" with as little as $100.Get all the information here. About Fortrea Stock (NASDAQ:FTRE)Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.Read More FTRE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart FTRE Stock News HeadlinesMay 13 at 11:38 AM | investorplace.comFTRE Stock Earnings: Fortrea Holdings Misses EPS, Misses Revenue for Q1 2024May 13 at 9:46 AM | msn.comFortrea Holdings Non-GAAP EPS of -$0.04 misses by $0.04, revenue of $662.1M misses by $92.48MMay 13 at 8:46 AM | seekingalpha.comFortrea Holdings Inc. 2024 Q1 - Results - Earnings Call PresentationMay 13 at 6:30 AM | globenewswire.comFortrea Reports First Quarter 2024 ResultsMay 12 at 6:44 PM | seekingalpha.comFortrea Holdings: Still Many Question Marks On This CRO PlayMay 9, 2024 | americanbankingnews.comFortrea Holdings Inc. (NASDAQ:FTRE) Given Consensus Recommendation of "Hold" by BrokeragesMay 6, 2024 | globenewswire.comFortrea Reschedules Release of First Quarter 2024 Financial Results and Conference CallApril 28, 2024 | seekingalpha.comFTRE Fortrea Holdings Inc.April 11, 2024 | globenewswire.comFortrea Announces Date for First Quarter 2024 Financial Results and Conference CallApril 1, 2024 | seekingalpha.comLaboratory Corporation: A Healthier Diagnosis, As Pandemic Headwinds DisappearMarch 12, 2024 | finance.yahoo.comFortrea Holdings Full Year 2023 Earnings: EPS Misses ExpectationsMarch 12, 2024 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Incyte (INCY), Fortrea Holdings Inc. (FTRE) and Abbott Labs (ABT)March 12, 2024 | msn.comFortrea Holdings Inc. (NASDAQ:FTRE) Q4 2023 Earnings Call TranscriptMarch 11, 2024 | msn.comStocks Close Mildly Lower on Caution Ahead of Tuesday’s U.S. CPI ReportMarch 11, 2024 | finanznachrichten.deFortrea Holdings Inc: Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital PartnersMarch 11, 2024 | markets.businessinsider.comFortrea Posts Loss In Q4; To Divest Endpoint Clinical And Patient Access BusinessesMarch 11, 2024 | bizjournals.comFortrea sells business units to PE firm for $345 millionMarch 11, 2024 | finance.yahoo.comFTRE Mar 2024 22.500 putMarch 11, 2024 | finance.yahoo.comFortrea Holdings Inc (FTRE) Reports Mixed 2023 Results and Sets 2024 GuidanceMarch 11, 2024 | seekingalpha.comFortrea Holdings Inc. 2023 Q4 - Results - Earnings Call PresentationMarch 11, 2024 | globenewswire.comFortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital PartnersMarch 11, 2024 | globenewswire.comFortrea Reports Fourth Quarter and Full-Year 2023 Results; Issues Full-Year 2024 GuidanceMarch 11, 2024 | finance.yahoo.comFTRE Mar 2024 30.000 putMarch 6, 2024 | markets.businessinsider.comKey Takeaways From Fortrea Holdings Analyst RatingsFebruary 29, 2024 | finance.yahoo.comFortrea Holdings Inc (K67.DU)See More Headlines Receive FTRE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fortrea and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/11/2024Today5/13/2024Next Earnings (Confirmed)5/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical laboratories Sub-IndustryN/A Current SymbolNASDAQ:FTRE CUSIPN/A CIK1965040 Webwww.fortrea.com Phone877-495-0816FaxN/AEmployees18,000Year FoundedN/APrice Target and Rating Average Stock Price Target$37.29 High Stock Price Target$44.00 Low Stock Price Target$27.00 Potential Upside/Downside+32.6%Consensus RatingHold Rating Score (0-4)2.38 Research Coverage8 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E Ratio26.52 P/E Growth1.65Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.90 Current Ratio1.62 Quick Ratio1.62 Sales & Book Value Annual Sales$3.11 billion Price / Sales0.81 Cash Flow$2.12 per share Price / Cash Flow13.28 Book Value$19.58 per share Price / Book1.44Miscellaneous Outstanding Shares89,370,000Free Float89,267,000Market Cap$2.51 billion OptionableOptionable BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Thomas H. Pike (Age 65)CEO, President & Chairman Comp: $2.19MMs. Jill McConnell (Age 49)Chief Financial Officer Comp: $735.39kMr. Mark A. Morais (Age 47)COO & President of Clinical Services Comp: $732.47kAmanda M. WarrenChief Accounting OfficerMs. Hima B. InguvaHead of Investor Relations & Corporate DevelopmentStillman HansonGeneral Counsel & Corporate SecretaryDr. John J. DoylePresident of ConsultingMore ExecutivesKey CompetitorsRadNetNASDAQ:RDNTGuardant HealthNASDAQ:GHVeracyteNASDAQ:VCYTViridian TherapeuticsNASDAQ:VRDNExact SciencesNASDAQ:EXASView All CompetitorsInsiders & InstitutionsUniSuper Management Pty LtdBought 17,612 shares on 5/13/2024Ownership: 0.020%O Shaughnessy Asset Management LLCBought 12,359 shares on 5/13/2024Ownership: 0.014%Covestor LtdBought 1,683 shares on 5/11/2024Ownership: 0.002%Viawealth LLCBought 5,651 shares on 5/10/2024Ownership: 0.006%Acadian Asset Management LLCSold 3,842 shares on 5/10/2024Ownership: 0.004%View All Insider TransactionsView All Institutional Transactions FTRE Stock Analysis - Frequently Asked Questions Should I buy or sell Fortrea stock right now? 8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Fortrea in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" FTRE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FTRE, but not buy additional shares or sell existing shares. View FTRE analyst ratings or view top-rated stocks. What is Fortrea's stock price target for 2024? 8 brokerages have issued 1 year price objectives for Fortrea's stock. Their FTRE share price targets range from $27.00 to $44.00. On average, they predict the company's share price to reach $37.29 in the next year. This suggests a possible upside of 32.6% from the stock's current price. View analysts price targets for FTRE or view top-rated stocks among Wall Street analysts. How have FTRE shares performed in 2024? Fortrea's stock was trading at $34.90 at the start of the year. Since then, FTRE stock has decreased by 19.5% and is now trading at $28.11. View the best growth stocks for 2024 here. How were Fortrea's earnings last quarter? Fortrea Holdings Inc. (NASDAQ:FTRE) issued its earnings results on Monday, March, 11th. The company reported $0.19 earnings per share for the quarter, missing analysts' consensus estimates of $0.23 by $0.04. The company had revenue of $775.40 million for the quarter, compared to the consensus estimate of $779.09 million. The company's revenue was up 1.8% on a year-over-year basis. What ETFs hold Fortrea's stock? ETFs with the largest weight of Fortrea (NASDAQ:FTRE) stock in their portfolio include LeaderShares Activist Leaders ETF (ACTV), Invesco S&P SmallCap Health Care ETF (PSCH), Invesco S&P Spin-Off ETF (CSD), iShares Factors US Value Style ETF (STLV), BlackRock Large Cap Value ETF (BLCV), Brandes U.S. Small-Mid Cap Value ETF (BSMC), Brandes U.S. Value ETF (BUSA) and Vanguard S&P Small-Cap 600 Value ETF (VIOV). What guidance has Fortrea issued on next quarter's earnings? Fortrea updated its FY 2024 earnings guidance on Monday, May, 13th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $2.8 billion-$2.9 billion, compared to the consensus revenue estimate of $3.1 billion. Who are Fortrea's major shareholders? Fortrea's stock is owned by many different institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (11.09%), Nordea Investment Management AB (1.10%), Penn Davis Mcfarland Inc. (0.64%), Principal Financial Group Inc. (0.54%), Mutual of America Capital Management LLC (0.41%) and First Eagle Investment Management LLC (0.30%). Insiders that own company stock include Peter M Neupert and Thomas Pike. View institutional ownership trends. How do I buy shares of Fortrea? Shares of FTRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:FTRE) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersGuard Against the Coming Financial UpheavalPorter & CompanyElon’s New Device is About to Shock the WorldInvestorPlaceTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityThe only AI company you should be looking atBehind the MarketsNo experience to confident trader, meet my student…Wealth Builders InstituteCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fortrea Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
